Maria Fizelova1, Manna Miilunpohja2, Antti J Kangas3, Pasi Soininen4, Johanna Kuusisto5, Mika Ala-Korpela6, Markku Laakso5, Alena Stančáková7. 1. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland. 2. Internal Medicine, Kuopio University Hospital, Kuopio, Finland. 3. Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland. 4. Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 5. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland; Internal Medicine, Kuopio University Hospital, Kuopio, Finland. 6. Computational Medicine, Institute of Health Sciences, University of Oulu, Oulu, Finland; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland; Oulu University Hospital, Oulu, Finland; Computational Medicine, School of Social and Community Medicine and the Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK. 7. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland. Electronic address: alena.stancakova@uef.fi.
Abstract
OBJECTIVE: We investigated the association of various lipoprotein traits, apolipoproteins and their ratios with the deterioration of glycemia, incident type 2 diabetes, insulin resistance and insulin secretion in a large population-based Metabolic Syndrome Men (METSIM) Study. RESEARCH DESIGN AND METHODS: The METSIM Study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. From 6607 non-diabetic participants without statin treatment at baseline, 386 developed incident type 2 diabetes during a 5.9-year follow-up. A total of 3330 non-diabetic participants without statin treatment had both baseline and follow-up visit data, and were included in statistical analyses of the worsening of glycemia. RESULTS: Compared to single lipid and lipoprotein measurements, lipoprotein and apolipoprotein ratios were better predictors of the glucose area under the curve and incident type 2 diabetes after adjustment for confounding factors. The apolipoprotein B/LDL cholesterol ratio was the strongest predictor of the worsening of glycemia, whereas the apolipoprotein A1/HDL cholesterol ratio was the strongest predictor of incident type 2 diabetes. The associations of lipoprotein traits, apolipoproteins and their ratios with insulin sensitivity were stronger than those with insulin secretion. CONCLUSIONS: The apolipoprotein B/LDL cholesterol and apolipoprotein A1/HDL cholesterol ratios were the strongest predictors of the worsening of glycemia and incident type 2 diabetes, respectively.
OBJECTIVE: We investigated the association of various lipoprotein traits, apolipoproteins and their ratios with the deterioration of glycemia, incident type 2 diabetes, insulin resistance and insulin secretion in a large population-based Metabolic Syndrome Men (METSIM) Study. RESEARCH DESIGN AND METHODS: The METSIM Study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. From 6607 non-diabetic participants without statin treatment at baseline, 386 developed incident type 2 diabetes during a 5.9-year follow-up. A total of 3330 non-diabetic participants without statin treatment had both baseline and follow-up visit data, and were included in statistical analyses of the worsening of glycemia. RESULTS: Compared to single lipid and lipoprotein measurements, lipoprotein and apolipoprotein ratios were better predictors of the glucose area under the curve and incident type 2 diabetes after adjustment for confounding factors. The apolipoprotein B/LDL cholesterol ratio was the strongest predictor of the worsening of glycemia, whereas the apolipoprotein A1/HDL cholesterol ratio was the strongest predictor of incident type 2 diabetes. The associations of lipoprotein traits, apolipoproteins and their ratios with insulin sensitivity were stronger than those with insulin secretion. CONCLUSIONS: The apolipoprotein B/LDL cholesterol and apolipoprotein A1/HDL cholesterol ratios were the strongest predictors of the worsening of glycemia and incident type 2 diabetes, respectively.
Authors: Preethi Mani; Hao-Yu Ren; Ian J Neeland; Darren K McGuire; Colby R Ayers; Amit Khera; Anand Rohatgi Journal: Diabetes Metab Syndr Date: 2016-12-12
Authors: Toni I Pollin; Paul W Franks; Tibor V Varga; Alexandra H Winters; Kathleen A Jablonski; Edward S Horton; Prajakta Khare-Ranade; William C Knowler; Santica M Marcovina; Frida Renström; Karol E Watson; Ronald Goldberg; José C Florez Journal: Circ Cardiovasc Genet Date: 2016-10-26
Authors: Markku Laakso; Johanna Kuusisto; Alena Stančáková; Teemu Kuulasmaa; Päivi Pajukanta; Aldons J Lusis; Francis S Collins; Karen L Mohlke; Michael Boehnke Journal: J Lipid Res Date: 2017-01-24 Impact factor: 5.922
Authors: Thore Buergel; Jakob Steinfeldt; Greg Ruyoga; Maik Pietzner; Daniele Bizzarri; Dina Vojinovic; Julius Upmeier Zu Belzen; Lukas Loock; Paul Kittner; Lara Christmann; Noah Hollmann; Henrik Strangalies; Jana M Braunger; Benjamin Wild; Scott T Chiesa; Joachim Spranger; Fabian Klostermann; Erik B van den Akker; Stella Trompet; Simon P Mooijaart; Naveed Sattar; J Wouter Jukema; Birgit Lavrijssen; Maryam Kavousi; Mohsen Ghanbari; Mohammad A Ikram; Eline Slagboom; Mika Kivimaki; Claudia Langenberg; John Deanfield; Roland Eils; Ulf Landmesser Journal: Nat Med Date: 2022-09-22 Impact factor: 87.241
Authors: Marta Guasch-Ferré; Adela Hruby; Estefanía Toledo; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu Journal: Diabetes Care Date: 2016-05 Impact factor: 19.112
Authors: Jennifer E Ho; Martin G Larson; Anahita Ghorbani; Susan Cheng; Ming-Huei Chen; Michelle Keyes; Eugene P Rhee; Clary B Clish; Ramachandran S Vasan; Robert E Gerszten; Thomas J Wang Journal: PLoS One Date: 2016-02-10 Impact factor: 3.240